Dr. Michael Schlossmacher was recently awarded the Canada Research Chair in Parkinson Disease
Ottawa Hospital Research Institute
Dr. Michael Schlossmacher
was recently awarded the Canada Research Chair in Parkinson Disease
On December 7, 2006, Dr. Michael Schlossmacher
was awarded a prestigious Canada Research Chair in Parkinson Disease.
Dr. Schlossmacher joined the Ottawa Hospital Research Institute as a Scientist in the Neuroscience Program in August 2006.
He is also an Associate Professor at the University of Ottawa (Division of Neurology, cross-appointed to the Department of Cellular and Molecular Medicine), and a neurologist at The Ottawa Hospital.
The goal of Dr. Schlossmacher's work as a physician-scientist is to contribute to the improved care of patients with neurodegenerative diseases.
In 1988, a Fulbright Commission scholarship enabled Dr. Schlossmacher
to visit Harvard University
and undergo scientific training in Alzheimer disease under Dr. Dennis Selkoe.
After residency training in medicine in Vienna, Dr. Schlossmacher returned to Boston to become a neurologist.
As of 2000, he focused his clinical practice and his research on Parkinson disease (at the Department of Neurology of Massachusetts General Hospital and at the Center for Neurologic Diseases at Brigham & Women's Hospital).
At the OHRI
, Dr. Schlossmacher
will be working closely with Dr. David Grimes, Dr. David Park, and other members of the Parkinson Research Consortium
• Dr. Schlossmacher's OHRI profile
• Dr. Schlossmacher's Canada Research Chair profile
• Dr. Schlossmacher's recently published review of the implications of Parkinson disease genetics